Parallel Advisors, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Parallel Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$14.37 - $19.07 $2,313 - $3,070	-161 Reduced 23.71%	518 $9,000
Q3 2023 May 20, 2024	BUY	$13.62 - $20.2 $572 - $848	42 Added 6.59%	679 $11,000
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $572 - $848	42 Added 6.59%	679 $11,000
Q2 2023 May 20, 2024	BUY	$10.44 - $16.48 $4,656 - $7,350	446 Added 233.51%	637 $8,000
Q2 2023 Aug 04, 2023	BUY	$10.44 - $16.48 $4,656 - $7,350	446 Added 233.51%	637 $8,000
Q1 2023 May 20, 2024	SELL	$10.7 - $15.79 $3,498 - $5,163	-327 Reduced 63.13%	191 $2,000
Q1 2023 Apr 25, 2023	BUY	$10.7 - $15.79 $2,043 - $3,015	191 New	191 $2,000
Q1 2022 Apr 28, 2022	SELL	$9.3 - $12.37 $223 - $296	-24 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$10.39 - $15.15 $249 - $363	24 New	24 $0

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.